Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:27:44.799Z.
Calculation as of: 2026-10-06T15:27:44.799Z.
Quote observation: 2026-10-06T15:25:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 691567571024a1250b647fc32e699128e911e71d0d99b5189d978a843a850df9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2020-08-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
6.75x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$174.73M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.21M
EV/EBITDA Ratio
213.31x
TTM Avg
57.51x
3Y Avg
54.12x
5Y Avg
36.92x
Market Cap
$179.60M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.13M
EV/EBITDA Ratio
142.65x
TTM Avg
155.63x
3Y Avg
70.41x
5Y Avg
70.41x
Market Cap
$166.35M
EV/EBITDA Ratio
10.47x
TTM Avg
86.42x
3Y Avg
168.75x
5Y Avg
173.55x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $173.41M | N/A | 6.75x | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $173.14M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $174.73M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.16M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.21M | 213.31x | 57.51x | 54.12x | 36.92x |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.60M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $180.13M | 142.65x | 155.63x | 70.41x | 70.41x |
| OptimizeRx Corp. (OPRX)vs › | $166.35M | 10.47x | 86.42x | 168.75x | 173.55x |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | N/A | 8.39x | 66.32x | 66.32x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2020-08-06 | 15.20x |
| 2020-08-05 | 15.13x |
| 2020-08-04 | 13.73x |
| 2020-08-03 | 14.12x |
| 2020-07-31 | 14.35x |
| 2020-07-30 | 14.39x |
| 2020-07-29 | 14.78x |
| 2020-07-28 | 14.66x |
| 2020-07-27 | 14.86x |
| 2020-07-24 | 15.17x |
| 2020-07-23 | 15.22x |
| 2020-07-22 | 14.51x |
| 2020-07-21 | 14.51x |
| 2020-07-20 | 14.08x |
| 2020-07-17 | 13.38x |
| 2020-07-16 | 13.50x |
| 2020-07-15 | 14.74x |
| 2020-07-14 | 13.85x |
| 2020-07-13 | 14.08x |
| 2020-07-10 | 12.80x |
| 2020-07-09 | 13.77x |
| 2020-07-08 | 13.07x |
| 2020-07-07 | 13.38x |
| 2020-07-06 | 13.38x |
| 2020-07-02 | 12.22x |
| 2020-07-01 | 12.22x |
| 2020-06-30 | 10.66x |
| 2020-06-29 | 9.50x |
| 2020-06-26 | 9.54x |
| 2020-06-25 | 9.81x |
| 2020-06-24 | 9.46x |
| 2020-06-23 | 9.58x |
| 2020-06-22 | 8.68x |
| 2020-06-19 | 9.69x |
| 2020-06-18 | 9.96x |
| 2020-06-17 | 9.15x |
| 2020-06-16 | 7.56x |
| 2020-06-15 | 6.70x |
| 2020-06-12 | 6.59x |
| 2020-06-11 | 6.28x |
| 2020-06-10 | 7.09x |
| 2020-06-09 | 6.97x |
| 2020-06-08 | 7.09x |
| 2020-06-05 | 7.23x |
| 2020-06-04 | 7.17x |
| 2020-06-03 | 7.09x |
| 2020-06-02 | 7.05x |
| 2020-06-01 | 7.04x |
| 2020-05-29 | 7.09x |
| 2020-05-28 | 6.90x |
| 2020-05-27 | 6.90x |
| 2020-05-26 | 7.25x |
| 2020-05-22 | 6.97x |
| 2020-05-21 | 6.90x |
| 2020-05-20 | 8.60x |
| 2020-05-19 | 8.51x |
| 2020-05-18 | 8.47x |
| 2020-05-15 | 8.37x |
| 2020-05-14 | 7.55x |
| 2020-05-13 | 7.84x |
| 2020-05-12 | 8.71x |
| 2020-05-11 | 8.71x |
| 2020-05-08 | 8.56x |
| 2020-05-07 | 8.80x |
| 2020-05-06 | 8.71x |
| 2020-05-05 | 8.71x |
| 2020-05-04 | 8.56x |
| 2020-05-01 | 8.71x |
| 2020-04-30 | 8.71x |
| 2020-04-29 | 8.47x |
| 2020-04-28 | 8.37x |
| 2020-04-27 | 8.61x |
| 2020-04-24 | 8.23x |
| 2020-04-23 | 8.23x |
| 2020-04-22 | 8.27x |
| 2020-04-21 | 7.74x |
| 2020-04-20 | 8.18x |
| 2020-04-17 | 8.66x |
| 2020-04-16 | 8.47x |
| 2020-04-15 | 8.66x |
| 2020-04-14 | 8.66x |
| 2020-04-13 | 7.02x |
| 2020-04-09 | 6.79x |
| 2020-04-08 | 6.49x |
| 2020-04-07 | 6.49x |
| 2020-04-06 | 6.30x |
| 2020-04-03 | 6.13x |
| 2020-04-02 | 6.30x |
| 2020-04-01 | 6.30x |
| 2020-03-31 | 6.64x |
| 2020-03-30 | 6.73x |
| 2020-03-27 | 7.02x |
| 2020-03-26 | 7.21x |
| 2020-03-25 | 6.87x |
| 2020-03-24 | 6.79x |
| 2020-03-23 | 6.73x |
| 2020-03-20 | 6.73x |
| 2020-03-19 | 7.26x |
| 2020-03-18 | 7.02x |
| 2020-03-17 | 8.27x |
| 2020-03-16 | 8.47x |
| 2020-03-13 | 9.24x |
| 2020-03-12 | 9.09x |
| 2020-03-11 | 10.20x |
| 2020-03-10 | 10.78x |
| 2020-03-09 | 9.82x |
| 2020-03-06 | 10.97x |
| 2020-03-05 | 11.12x |
| 2020-03-04 | 11.65x |
| 2020-03-03 | 12.51x |
| 2020-03-02 | 12.27x |
| 2020-02-28 | 12.42x |
| 2020-02-27 | 10.54x |
| 2020-02-26 | 10.63x |
| 2020-02-25 | 4.87x |
| 2020-02-24 | 5.30x |
| 2020-02-21 | 5.42x |
| 2020-02-20 | 5.48x |
| 2020-02-19 | 5.46x |
| 2020-02-18 | 5.44x |
| 2020-02-14 | 5.40x |
| 2020-02-13 | 5.40x |
| 2020-02-12 | 5.40x |
| 2020-02-11 | 5.46x |
| 2020-02-10 | 5.44x |
| 2020-02-07 | 5.46x |
| 2020-02-06 | 5.59x |
| 2020-02-05 | 5.61x |
| 2020-02-04 | 5.65x |
| 2020-02-03 | 5.61x |
| 2020-01-31 | 5.51x |
| 2020-01-30 | 5.59x |
| 2020-01-29 | 5.53x |
| 2020-01-28 | 5.55x |
| 2020-01-27 | 5.57x |
| 2020-01-24 | 5.55x |
| 2020-01-23 | 5.57x |
| 2020-01-22 | 5.59x |
| 2020-01-21 | 5.61x |
| 2020-01-17 | 5.51x |
| 2020-01-16 | 5.46x |
| 2020-01-15 | 5.51x |
| 2020-01-14 | 5.48x |
| 2020-01-13 | 5.50x |
| 2020-01-10 | 5.51x |
| 2020-01-09 | 5.40x |
| 2020-01-08 | 5.48x |
| 2020-01-07 | 5.50x |
| 2020-01-06 | 5.36x |
| 2020-01-03 | 5.55x |
| 2020-01-02 | 5.63x |
| 2019-12-31 | 5.65x |
| 2019-12-30 | 5.53x |
| 2019-12-27 | 5.50x |
| 2019-12-26 | 5.54x |
| 2019-12-24 | 5.36x |
| 2019-12-23 | 5.44x |
| 2019-12-20 | 5.52x |
| 2019-12-19 | 5.40x |
| 2019-12-18 | 5.53x |
| 2019-12-17 | 5.51x |
| 2019-12-16 | 5.69x |
| 2019-12-13 | 5.65x |
| 2019-12-12 | 5.46x |
| 2019-12-11 | 5.46x |
| 2019-12-10 | 5.44x |
| 2019-12-09 | 5.53x |
| 2019-12-06 | 5.18x |
| 2019-12-05 | 4.95x |
| 2019-12-04 | 5.38x |
| 2019-12-03 | 5.46x |
| 2019-12-02 | 5.44x |
| 2019-11-29 | 5.44x |
| 2019-11-27 | 5.42x |
| 2019-11-26 | 5.34x |
| 2019-11-25 | 5.44x |
| 2019-11-22 | 5.46x |
| 2019-11-21 | 5.42x |
| 2019-11-20 | 5.75x |
| 2019-11-19 | 5.67x |
| 2019-11-18 | 5.48x |
| 2019-11-15 | 5.55x |
| 2019-11-14 | 4.27x |
| 2019-11-13 | 3.85x |
| 2019-11-12 | 3.91x |
| 2019-11-11 | 3.89x |
| 2019-11-08 | 4.14x |
| 2019-11-07 | 4.03x |
| 2019-11-06 | 3.91x |
| 2019-11-05 | 4.08x |
| 2019-11-04 | 4.20x |
| 2019-11-01 | 3.99x |
| 2019-10-31 | 4.01x |
| 2019-10-30 | 3.87x |
| 2019-10-29 | 4.03x |
| 2019-10-28 | 3.99x |
| 2019-10-25 | 3.72x |
| 2019-10-24 | 3.82x |
| 2019-10-23 | 3.90x |
| 2019-10-22 | 3.85x |
| 2019-10-21 | 3.80x |
| 2019-10-18 | 3.76x |
| 2019-10-17 | 3.61x |
| 2019-10-16 | 3.78x |
| 2019-10-15 | 4.08x |
| 2019-10-14 | 4.16x |
| 2019-10-11 | 4.10x |
| 2019-10-10 | 4.12x |
| 2019-10-09 | 4.03x |
| 2019-10-08 | 4.06x |
| 2019-10-07 | 4.14x |
| 2019-10-04 | 4.16x |
| 2019-10-03 | 4.22x |
| 2019-10-02 | 4.05x |
| 2019-10-01 | 4.27x |
| 2019-09-30 | 4.52x |
| 2019-09-27 | 4.30x |
| 2019-09-26 | 4.50x |
| 2019-09-25 | 4.56x |
| 2019-09-24 | 4.73x |
| 2019-09-23 | 5.00x |
| 2019-09-20 | 4.71x |
| 2019-09-19 | 4.43x |
| 2019-09-18 | 4.27x |
| 2019-09-17 | 4.85x |
| 2019-09-16 | 4.47x |
| 2019-09-13 | 4.54x |
| 2019-09-12 | 4.52x |
| 2019-09-11 | 4.52x |
| 2019-09-10 | 4.47x |
| 2019-09-09 | 4.54x |
| 2019-09-06 | 4.22x |
| 2019-09-05 | 4.41x |
| 2019-09-04 | 4.43x |
| 2019-09-03 | 4.54x |
| 2019-08-30 | 4.43x |
| 2019-08-29 | 4.56x |
| 2019-08-28 | 4.29x |
| 2019-08-27 | 4.20x |
| 2019-08-26 | 4.41x |
| 2019-08-23 | 4.16x |
| 2019-08-22 | 4.41x |
| 2019-08-21 | 4.29x |
| 2019-08-20 | 4.03x |
| 2019-08-19 | 4.14x |
| 2019-08-16 | 3.59x |
| 2019-08-15 | 3.64x |
| 2019-08-14 | 4.16x |
| 2019-08-13 | 4.47x |